Drug Trial Radar · NCT00710086
Intravenous Remifentanil for Labor Analgesia
Last checked: Nov 19, 2026Latest source record: Sep 18, 2009 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
1,000
Actual
Start
Jul 2008
Primary completion
Sep 2009
Study completion Sep 2009
Sponsor
- Lead sponsor
- Nanjing Medical UniversityAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- HRSA/Maternal and Child Health Bureau
- First posted
- Jul 4, 2008
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- Who can join
- Female only, from 18 years, up to 45 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Labor analgesia is an essential health caring procedure for women. However, epidural analgesia cannot be performed on all subjects for different contraindications, such as lower platelet counter, back infection at the puncture site, and fear of epidural injection etc. Therefore, intravenous analgesia is an alternative for such conditions. Given the influence of intravenous administration of drugs on fetus, the drug selection is very important. Remifentanil, a super-short efficacious opioid, can last for 3-4 minutes after injection, which is similar in both maternal and fetal environment. Thus the fetus-associated side effects would be less than other drugs. The investigators hypothesized that remifentanil would be a superior intravenous drug used with patient-controlled technique for labor analgesia.
Conditions
- Labor Pain
Interventions
HydromorphoneDrug
Intravenous administration of hydromorphone 1mg at the patient's request if they felt uterine contraction pain
RemifentanilDrug
Remifentanil intravenous PCA: 0.2μg/kg, lockout time interval 2 minutes, continuous infusion rate 0.2-0.8μg/kg/min.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Maternal Visual Analog Scale (VAS) rating of painTime frame: Prior to analgesia, latent phrase, active phrase, second stage of labor, posterior to vaginal delivery
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Nanjing Maternal and Child Health Care Hospital
Nanjing, Jiangsu, China
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.